SOS Small Cell Lung Cancer AECC

El cáncer de pulmón en mujeres ya provoca casi tantas muertes como el de mama en España Este año se diagnosticarán 296.103 nuevos casos de cáncer en España, un 3,29 % más que en 2024, según la estimación anual que hace la Sociedad Española de Oncología Médica (SEOM)

El cáncer de pulmón aumenta en mujeres y arrasa en España. En la red SOSCLC.ORG trabajaremos en las bases científicas y las implicaciones sociales de este problema!
www.eldiario.es/sociedad/can...

2024 approvals: Summary of 14 new drugs/indications in #LungCancer by FDA

1. #Tepotinib
2. #Osimertinib x2
3. #Alectinib
4. #Tarlatamab
5. #Zenocutuzumab
6. #Durvalumab x2
7. #Amivantamab x2
8. #Nivolumab (now SubQ)
9. #Ensartinib

#lcsm #OncSky #MedSky #Cancer

5 papers about Lung Cancer suggested by Stephen Liu - OncoDaily 5 papers about Lung Cancer suggested by Stephen Liu / Alessandro Brunelli, Anne Gulbech Ording, cancer, Dániel Sztankovics, Georgetown University, Jii Bum

5 papers about Lung Cancer suggested by Stephen Liu
@stephenvliu.bsky.social

oncodaily.com/science/step...

#Cancer #GeorgetownUniversity #LungCancer #Nivolumab #NSCLC #OncoDaily #Oncology #Osimertinib #Health #PATHER2study #SCLC #TimeToxicity #Medicine

Our lab malumbreslab.org @vhio.bsky.social will join CIBERONC in 2025. Thanks for counting on us!! www.ciberonc.es/en

Por qué es importante ajustar las terapias oncológicas a los ritmos circadianos de los pacientes Las últimas investigaciones señalan el gran potencial terapéutico de la cronoterapia

@casanova-acebes.bsky.social, a member of the @sosclc-aecc.bsky.social, receives an ERC grant to improve cancer therapies! elpais.com/salud-y-bien...

Follow our #SLCL starter pack for more news on #lung #cancer #oncosky #oncsky 🧪

Our @sosclc-aecc.bsky.social researcher @crismayorruiz.bsky.social reports a new therapeutic strategy against #lung #cancer. A perfect example of the ideas to be developed within the #SCLC network! #oncosky #oncsky 🧪

Real-world analysis of 1L carboplatin, etoposide, atezolizumab for extensive stage #SCLC with ≥3y f/u published in Lung Cancer. In 207 pts, the 3y OS rate was 21%. Need to build on this backbone, but long-term survival is possible for some. #LCSM #OncSky

www.lungcancerjournal.info/article/S016...

The OncoAlert 🚨Newsletter NOW OUT Covering September November 28-Dec 5, 2024

REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0

✅FDA Approves Duvalumab in #SCLC 🫁🇺🇸
✅FDA ACCELERATED APPROVAL TO
ZENOCUTUZUMAB-ZBCO IN #NSCLC 🫁
✅Lung adenocarcinomas with mucinous & more

A starter pack with researchers, clinicians, associations and patients wirh interest in Small Cell Lung Cancer #SCLC and related lung neuroendocrine tumors. Please contact us if interested in being included or have any suggestion go.bsky.app/HmjASG1

Living with lung cancer isn’t just about battling a disease; it’s about navigating an entirely different reality. These quotes are a glimpse into the struggles, fears, and uncertainties faced by those living with young lung cancer every day. 💔

#LivingWithLungCancer #CancerAdvocacy #lcsm

@sosclc-aecc.bsky.social researcher Dolores Isla talks in El Mundo about current challenges in lung cancer..

A Starter Pack with Small Cell Lung Cancer #SCLC accounts!
#oncsky #oncosky 🧪

Done!!

Done!! 😁

A starter pack with researchers, clinicians, associations and patients wirh interest in Small Cell Lung Cancer #SCLC and related lung neuroendocrine tumors. Please contact us if interested in being included or have any suggestion go.bsky.app/HmjASG1

7 lung cancer patient advocates in 2018

Why #lungcancer (the #1 cancer killer) needs more funding and research:
Only 2 of the 7 LC patient advocates in this 2018 photo are still alive (including me). While newer treatments like targeted therapy and immune checkpoint inhibitors are effective for some, they don't work for all. #LCSM

FDA approves durvalumab for limited-stage small cell lung cancer On December 4, 2024, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) for limited-stage small cell lung cancer (LS-SCLC).

New therapies in SCLC: FDA approves durvalumab for limited-stage small cell lung cancer
www.fda.gov/drugs/resour...

An insightful review on genetics and resistance to immunotherapies in cancer by @sosclc-aecc.bsky.social researcher @franmj88.bsky.social @vhio.bsky.social www.cell.com/trends/cance...

2 new studies in Nature reveal how isoprene—a gas from plants—forms particles in the upper atmosphere, improving climate models. Better understanding of air quality & particle behaviour could aid future research into impacts on lung health inclu. #lungcancer #LCSM

www.nature.com/nature/volum...